Refractory Desmoplastic Small Round Cell Tumor: Clinical Trials

3 trials for Refractory Desmoplastic Small Round Cell Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 recruiting. 2 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Terminated 1
Early Phase 11Terminated 1

Follow Refractory Desmoplastic Small Round Cell Tumor: new trials by email Literature Review of Refractory Desmoplastic Small Round Cell Tumor trials Research Report on Refractory Desmoplastic Small Round Cell Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
Biospecimen Collection, Computed Tomography, Echocardiography Test - Desmoplastic Small Round Cell Tumor, Osteosarcoma
Phase 2RecruitingNational Cancer Institute (NCI)552021-03-082026-10-13
Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults
Allogeneic Hematopoietic Stem Cell Transplantation, Cyclosporine, Etoposide - Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Phase 2TerminatedM.D. Anderson Cancer Center12020-08-192025-06-29
Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients
Cisplatin, Cytoreductive Surgery, Doxorubicin - Malignant Abdominal Neoplasm, Malignant Pelvic Neoplasm
Early Phase 1TerminatedMayo Clinic22019-11-082025-02-20

Narrower conditions

Desmoplastic Small Round Cell Tumor (3)  ·  Rhabdomyosarcoma (2)  ·  Colonic Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Liposarcoma (1)  ·  Mesothelioma, Malignant (1)  ·  Neuroblastoma (1)  ·  Neuroectodermal Tumors, Primitive, Peripheral (1)  ·  Neurofibrosarcoma (1)  ·  Osteosarcoma (1)  ·  Ovarian Neoplasms (1)  ·  Pelvic Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Sarcoma (1)  ·  Stomach Neoplasms (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Myosarcoma (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Muscle Tissue (2)  ·  Sarcoma (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Adenoma (1)  ·  Adnexal Diseases (1)

Interventions

Magnetic Resonance Spectroscopy (2)  ·  Specimen Handling (2)  ·  1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Antilymphocyte Serum (1)  ·  Cisplatin (1)  ·  Cyclosporine (1)  ·  Cyclosporins (1)  ·  Cytoreduction Surgical Procedures (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Hyperthermic Intraperitoneal Chemotherapy (1)  ·  Melphalan (1)  ·  Mycophenolic Acid (1)  ·  Platinum (1)  ·  Stem Cell Transplantation (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (3)

Top investigators

Damon R Reed (1)  ·  Jeremy S Connors, MD (1)  ·  Patricio C. Gargollo, M.D. (1)

Results publications

PMID 42131734

NIH funding

UM1CA228823 (1)